AnalystsMadhu KumarMadhu Kumar's Stock Forecasts
AnalystsMadhu Kumar
Analyst Ranking
Top 3%
#77 out of 3582 analysts
Average Return
+33.79%
Win Rate
56%31 out of 55
Risk vs Reward
Poor
Good
Madhu Kumar's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Catalyst Biosciences IncCBIO | +450.00% | $4.38 | $24.09 | 2017-06-11 - 2018-06-12 | Strong Buy |
Scholar Rock Holding CorpSRRK | +331.26% | $14.97 | $64.56 | 2020-03-11 - 2021-03-12 | Buy |
Arbutus Biopharma CorpABUS | +309.92% | $1.21 | $4.96 | 2020-03-26 - 2020-07-24 | Buy |
Clementia Pharmaceuticals IncCMTA | +211.47% | $8.46 | $26.35 | 2018-08-14 - 2019-04-17 | Strong Buy |
Arcturus Therapeutics Holdings IncARCT | +206.96% | $13.80 | $42.36 | 2020-02-10 - 2020-12-29 | Buy |
Madhu Kumar's Stock Coverage
| Name / Ticker | # of Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Passage BIO IncPASG | 1 | Hold | $6.00 | +21.21% | Downgrades | 6 days ago |
Arrowhead Pharmaceuticals IncARWR | 5 | Strong Buy | N/A | N/A | Upgrades | 6 days ago |
Design Therapeutics IncDSGN | 1 | Strong Sell | $10.00 | -14.97% | Initiates Coverage On | 6 days ago |
Arvinas IncARVN | 1 | Strong Buy | $157.00 | +129.26% | Initiates Coverage On | 6 days ago |
Magenta Therapeutics IncMGTA | 1 | Strong Buy | $8.00 | +128.57% | Upgrades | 19 days ago |
Horizon Therapeutics Public Ltd CoHZNP | 1 | Strong Buy | $168.00 | +93.44% | Upgrades | 2 months ago |
Applied Therapeutics IncAPLT | 1 | Strong Sell | $10.00 | +200.30% | Downgrades | 5 months ago |
Dicerna Pharmaceuticals IncDRNA | 5 | Hold | $25.00 | -34.59% | Downgrades | 5 months ago |
Arcturus Therapeutics Holdings IncARCT | 3 | Strong Sell | $29.00 | +16.47% | Downgrades | 5 months ago |
Dynavax Technologies CorpDVAX | 1 | Strong Buy | $19.00 | +50.79% | Initiates Coverage On | 6 months ago |
Krystal Biotech IncKRYS | 1 | Strong Buy | $90.00 | +57.73% | Upgrades | 6 months ago |
Intellia Therapeutics IncNTLA | 5 | Hold | $85.00 | -3.64% | Maintains | 7 months ago |
Iovance Biotherapeutics IncIOVA | 2 | Strong Buy | $97.00 | +558.52% | Initiates Coverage On | 9 months ago |
Apellis Pharmaceuticals IncAPLS | 5 | Strong Buy | $130.00 | +235.22% | Initiates Coverage On | 9 months ago |
Editas Medicine IncEDIT | 3 | Strong Sell | $20.00 | +8.23% | Initiates Coverage On | 9 months ago |
Cellectis SACLLS | 2 | Buy | $39.00 | +491.81% | Upgrades | 10 months ago |
Gritstone bio IncGRTS | 1 | Sell | $8.00 | N/A | Downgrades | a year ago |
Cellular Biomedicine Group IncCBMG | 2 | Hold | $19.00 | N/A | Downgrades | a year ago |
uniQure NVQURE | 2 | Buy | $57.00 | N/A | Upgrades | a year ago |
Arbutus Biopharma CorpABUS | 8 | Hold | N/A | N/A | Downgrades | 2 years ago |
Aprea Therapeutics IncAPRE | 1 | Buy | $45.00 | N/A | Initiates Coverage On | 2 years ago |
Vir Biotechnology IncVIR | 1 | Sell | $20.00 | N/A | Maintains | 2 years ago |
Pieris Pharmaceuticals IncPIRS | 1 | Buy | $5.00 | N/A | Upgrades | 2 years ago |
Scholar Rock Holding CorpSRRK | 1 | Buy | $35.00 | N/A | Initiates Coverage On | 2 years ago |
Leap Therapeutics IncLPTX | 1 | Buy | $6.00 | N/A | Initiates Coverage On | 2 years ago |
Spark Therapeutics IncONCE | 1 | Strong Buy | $71.00 | N/A | Upgrades | 3 years ago |
EyePoint Pharmaceuticals IncEYPT | 1 | Strong Buy | $6.00 | N/A | Maintains | 3 years ago |
Assembly Biosciences IncASMB | 3 | Strong Buy | $42.00 | N/A | Upgrades | 3 years ago |
Tetraphase Pharmaceuticals IncTTPH | 1 | Strong Buy | $7.00 | N/A | Maintains | 3 years ago |
Immunomedics IncIMMU | 1 | Strong Buy | $55.00 | N/A | Maintains | 3 years ago |
Clementia Pharmaceuticals IncCMTA | 2 | Strong Buy | $16.00 | N/A | Maintains | 3 years ago |
Alnylam Pharmaceuticals IncALNY | 2 | Strong Buy | $230.00 | N/A | Maintains | 3 years ago |
Regulus Therapeutics IncRGLS | 3 | Hold | $0.50 | N/A | Maintains | 4 years ago |
Deciphera Pharmaceuticals IncDCPH | 1 | Hold | N/A | N/A | Downgrades | 4 years ago |
Catalyst Biosciences IncCBIO | 2 | Strong Buy | $75.00 | N/A | Maintains | 4 years ago |
InflaRx NVIFRX | 1 | Strong Buy | $40.00 | N/A | Initiates Coverage On | 4 years ago |
Akari Therapeutics PlcAKTX | 3 | Hold | $3.00 | N/A | Initiates Coverage On | 4 years ago |
Achillion Pharmaceuticals IncACHN | 1 | Hold | $3.50 | N/A | Initiates Coverage On | 4 years ago |
Syndax Pharmaceuticals IncSNDX | 1 | Strong Buy | $40.00 | N/A | Initiates Coverage On | 4 years ago |
Tg Therapeutics IncTGTX | 1 | Strong Buy | $21.50 | N/A | Reinstates | 4 years ago |
CRISPR Therapeutics AGCRSP | 1 | Strong Buy | $23.50 | N/A | Initiates Coverage On | 5 years ago |
©2022 WallStreetZen
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.